Skip to main content

Table 4 Known-Group Validity of MDASI-Immunotherapy EPT by ECOG PS

From: Translation and validation of chinese version of MDASI immunotherapy for early-phase trials module: a cross-sectional study

MDASI-Immunotherapy Subscale

Mean ± SD

P

Mean severity (20)

  

Good

1.27 ± 1.26

< 0.001

Poor

3.92 ± 1.76

 

Mean core symptoms (13)

  

Good

1.02 ± 0.99

< 0.001

Poor

3.32 ± 1.71

 

Mean specific symptoms (7)

  

Good

1.02 ± 1.07

< 0.001

Poor

3.43 ± 1.77

 

Mean interference (6)

  

Good

0.88 ± 1.36

< 0.001

Poor

2.96 ± 2.15